UCB0022
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for UCB0022, covering 2025-11-18 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease [Phase 2]